← All themes
Pharmaceuticals stocks
제약
What are Pharmaceuticals stocks in Korea?
The Pharmaceuticals theme on jonbur groups 104 Korean stocks listed on KOSPI and KOSDAQ, worth ₩177T in total. On Oct 26, 2026 the group moved down 1.99% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.
Key facts
- Stocks
- 104
- Total market value
- ₩177T
- Day's move
- −1.99%
- As of
- Oct 26, 2026
- Largest members
- Samsung Biologics, Celltrion, Alteogen
Earnings tracker · 3Q 2026
Reporting season · reports due by Nov 14
6 of 98 reportedOperating profit up vs a year ago: 4 of 6
Revenue+26.6%
Operating profit+47.4%
Net profit−98.2%
Combined, for the companies that have reported, vs the same quarter a year ago
| Company | Reported | Revenue | vs a year ago | Operating profit | vs a year ago | vs last quarter | Op. margin |
|---|---|---|---|---|---|---|---|
| Celltrion | Oct 12Preliminary | ₩1.5T | +45.8% | ₩510B | +69.2% | +12.9% | 34.0%29.3% |
| Hanmi Pharm | Oct 27Preliminary | ₩377B | +4.2% | ₩38B | −31.3% | −71.2% | 10.0%15.2% |
| ST Pharm | Oct 27Preliminary | ₩98B | +19.1% | ₩16B | +6.6% | −14.3% | 16.1%18.0% |
| Boryung | Oct 22Preliminary | ₩314B | +12.3% | ₩25B | −13.4% | +7.1% | 8.1%10.5% |
| Bukwang Pharmaceutical IND | Oct 23Preliminary | ₩58B | +21.2% | ₩2.2B | +120.7% | +53.3% | 3.7%2.0% |
| Dong-A ST | Oct 27Preliminary | ₩207B | −4.4% | ₩21B | +52.9% | +239.9% | 10.4%6.5% |
| Hyundai Pharmaceutical | Expected around Oct 15 | ||||||
| Samsung Biologics | Expected around Oct 28 | ||||||
| Hanmi Science | Expected around Oct 29 | ||||||
| HK inno.N | Expected around Oct 29 | ||||||
| Dong-A Pharmaceutical | Expected around Oct 29 | ||||||
| Korea United Pharm | Expected around Oct 30 | ||||||
| Handok | Expected around Oct 30 | ||||||
| Myungin Pharm | Expected around Oct 31 | ||||||
| Whanin Pharm | Expected around Oct 31 | ||||||
| Kyongbo Pharmaceutical | Expected around Oct 31 | ||||||
| Samik Pharm | Expected around Oct 31 | ||||||
| GC Biopharma | Expected around Nov 3 | ||||||
| Chong Kun Dang Pharmaceutical | Expected around Nov 3 | ||||||
| JW Pharmaceutical | Expected around Nov 3 | ||||||
| GC WellBeing | Expected around Nov 3 | ||||||
| Yuhan | Expected around Nov 5 | ||||||
| Yungjin Pharm | Expected around Nov 5 | ||||||
| JW Lifescience | Expected around Nov 5 | ||||||
| IL Dong Pharmaceutical | Expected around Nov 6 | ||||||
| Ildong Holdings | Expected around Nov 6 | ||||||
| Kolmar Korea | Expected around Nov 7 | ||||||
| Daewoong Pharma | Expected around Nov 7 | ||||||
| Huons | Expected around Nov 10 | ||||||
| Vivozon Pharmaceutical | Expected around Nov 10 | ||||||
| GL Pharm Tech | Expected around Nov 10 | ||||||
| CTC Bio | Expected around Nov 12 | ||||||
| Suheung | Expected around Nov 13 | ||||||
| Ilyang Pharmaceutical | Expected around Nov 13 | ||||||
| Sam-A Pharm | Expected around Nov 13 | ||||||
| CMG Pharmaceutical | Expected around Nov 13 | ||||||
| Daehan Nupharm | Expected around Nov 13 | ||||||
| Shinil Pharmaceutical | Expected around Nov 13 | ||||||
| Hwail Pharm | Expected around Nov 13 | ||||||
| Poongjeon Pharmacy | Expected around Nov 13 | ||||||
| Alteogen | Expected around Nov 14 | ||||||
| HLB | Expected around Nov 14 | ||||||
| SAM Chun Dang Pharm | Expected around Nov 14 | ||||||
| D&D Pharmatech | Expected around Nov 14 | ||||||
| Celltrion Pharm | Expected around Nov 14 | ||||||
| DongKook Pharmaceutical | Expected around Nov 14 | ||||||
| Daewoong | Expected around Nov 14 | ||||||
| Komipharm International | Expected around Nov 14 | ||||||
| Shinpoong Pharmaceutical | Expected around Nov 14 | ||||||
| HLB Pharmaceutical | Expected around Nov 14 | ||||||
| T&L | Expected around Nov 14 | ||||||
| Kwangdong Pharmaceutical | Expected around Nov 14 | ||||||
| Huons Global | Expected around Nov 14 | ||||||
| Samjin Pharmaceutical | Expected around Nov 14 | ||||||
| Humedix | Expected around Nov 14 | ||||||
| KolmarBNH | Expected around Nov 14 | ||||||
| Union Korea Pharm | Expected around Nov 14 | ||||||
| Reyon Pharmaceutical | Expected around Nov 14 | ||||||
| DAE HWA Pharm | Expected around Nov 14 | ||||||
| Chongkundang Holdings | Expected around Nov 14 | ||||||
| Samil Pharmaceutical | Expected around Nov 14 | ||||||
| Daehan Pharmaceutical | Expected around Nov 14 | ||||||
| Kyungdong Pharm | Expected around Nov 14 | ||||||
| Hana Pharm | Expected around Nov 14 | ||||||
| Dongwha Pharm | Expected around Nov 14 | ||||||
| Jeil Pharmaceutical | Expected around Nov 14 | ||||||
| Ahn-Gook Pharmaceutical | Expected around Nov 14 | ||||||
| Samsung Pharmaceutical | Expected around Nov 14 | ||||||
| Dongsung Pharmaceutical | Expected around Nov 14 | ||||||
| Jeil Pharma Holdings | Expected around Nov 14 | ||||||
| Optus Pharmaceutical | Expected around Nov 14 | ||||||
| Icure Pharmaceutical Incorporation | Expected around Nov 14 | ||||||
| High Tech Pharm | Expected around Nov 14 | ||||||
| DongKoo Bio & Pharma | Expected around Nov 14 | ||||||
| Korea Pharma | Expected around Nov 14 | ||||||
| Withus Pharmaceutical | Expected around Nov 14 | ||||||
| Polaris AI Pharma | Expected around Nov 14 | ||||||
| Kukje Pharma | Expected around Nov 14 | ||||||
| Sinsin Pharmaceutical | Expected around Nov 14 | ||||||
| Yuyu Pharma | Expected around Nov 14 | ||||||
| BL Pharmtech | Expected around Nov 14 | ||||||
| JIN Yang Pharmaceutical | Expected around Nov 14 | ||||||
| CJ Bioscience | Expected around Nov 14 | ||||||
| Myungmoon Pharm | Expected around Nov 14 | ||||||
| Kyung NAM Pharm | Expected around Nov 14 | ||||||
| Korean Drug | Expected around Nov 14 | ||||||
| Korea Arlico Pharm | Expected around Nov 14 | ||||||
| Bcworldpharm | Expected around Nov 14 | ||||||
| Tdspharm | Expected around Nov 14 | ||||||
| Seoul Pharma | Expected around Nov 14 | ||||||
| Telcon RF Pharmaceutical | Expected around Nov 14 | ||||||
| ChoA Pharmaceutical | Expected around Nov 14 | ||||||
| Kmpharmaceutical | Expected around Nov 14 | ||||||
| HEM Pharma | Expected around Nov 28 | ||||||
| Daewon Pharmaceutical | Not yet | ||||||
| NovMetaPharma | Not yet | ||||||
| BASKHANBIOPharma | Not yet | ||||||
| Plumbline Life Sciences | Not yet | ||||||
Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.
Technical breadth
After the close on Oct 26, 2026- Above 20-day average
- 7%
- Above 60-day average
- 18%
- RSI above 70
- 0%
- RSI below 30
- 17%
- 52-week highs
- 0
- 52-week lows
- 13
Index gauge · Short term
Bearish
0 bullish, 2 neutral, 7 bearish
Index gauge · Medium term
Bearish
0 bullish, 1 neutral, 7 bearish
Technical read
Across the 100 Pharmaceuticals members, 7 trade above their 20-day average and 18 above their 60-day average, indicating weak short-term breadth against a longer-term base that is still partly intact. Oversold readings are notable, with 17 members showing RSI in the low range and none in the high range, while 13 members have set 52-week lows and none have set 52-week highs. The equal-weighted member index sits below its cloud with an RSI of 33.7, and both its short-term and medium-term gauges read bearish with no bullish signals.
Written by AI from the indicator values above. Not advice.
Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Credit & macro
- MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
- MaturitiesOct 22, 202675Boryung: ₩86bn of bonds due in the next 6 months vs ₩50bn cash₩86bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.Boryung
Pharmaceuticals
−1.82%제약
The pharmaceuticals theme in Korea covers companies that develop, manufacture, and sell prescription drugs, generic medicines, and over-the-counter products, along with some firms focused on contract drug manufacturing and biosimilars. Korean investors often group these companies together because they share regulatory frameworks, drug approval processes, and sensitivity to healthcare policy such as national insurance pricing decisions. The theme is also closely watched for research pipeline news, export deals, and clinical trial results.
104 companies · 14 up · 7 flat · 83 down
- Traded value
- ₩341B
- Value vs 20-day average
- 0.51×
- Top gainer
- Icure Pharmaceutical Incorporation +9.21%
- Largest company
- Samsung Biologics ₩67T
Companies in this theme
| Company | Price | Daily | Traded value | Market cap | NPS |
|---|---|---|---|---|---|
Samsung Biologics207940 · KOSPI | ₩1,452,000 | −0.95% | ₩50B | ₩67T | 6.88% |
Celltrion068270 · KOSPI | ₩190,000 | −2.26% | ₩82B | ₩44T | 7.28% |
Alteogen196170 · KOSDAQ | ₩218,500 | −2.67% | ₩36B | ₩15T | 2.68% |
Yuhan000100 · KOSPI | ₩81,700 | −3.54% | ₩14B | ₩6T | 6.83% |
HLB028300 · KOSDAQ | ₩39,250 | −5.65% | ₩18B | ₩5.2T | 1.16% |
Hanmi Pharm128940 · KOSPI | ₩352,500 | −2.49% | ₩24B | ₩4.5T | 9.61% |
SAM Chun Dang Pharm000250 · KOSDAQ | ₩188,900 | −5.17% | ₩17B | ₩4.4T | 1.34% |
Hanmi Science008930 · KOSPI | ₩42,250 | +1.56% | ₩4.8B | ₩2.9T | 6.27% |
Kolmar Korea161890 · KOSPI | ₩117,400 | −4.16% | ₩27B | ₩2.8T | 12.68% |
D&D Pharmatech347850 · KOSDAQ | ₩40,650 | −0.25% | ₩13B | ₩1.9T | 1.75% |
ST Pharm237690 · KOSDAQ | ₩88,500 | −1.56% | ₩4B | ₩1.8T | 5.77% |
Celltrion Pharm068760 · KOSDAQ | ₩36,500 | −2.93% | ₩1.5B | ₩1.6T | 0.49% |
GC Biopharma006280 · KOSPI | ₩129,600 | −1.97% | ₩1.7B | ₩1.5T | 6.68% |
Daewoong Pharma069620 · KOSPI | ₩100,600 | −1.76% | ₩1.7B | ₩1.2T | 10.30% |
DongKook Pharmaceutical086450 · KOSDAQ | ₩23,400 | −4.29% | ₩9.7B | ₩1.1T | 3.33% |
HK inno.N195940 · KOSDAQ | ₩33,050 | −3.08% | ₩2B | ₩936B | 5.03% |
Chong Kun Dang Pharmaceutical185750 · KOSPI | ₩61,900 | −4.33% | ₩999M | ₩854B | 6.34% |
Daewoong003090 · KOSPI | ₩14,510 | −2.94% | ₩624M | ₩844B | 3.25% |
Boryung003850 · KOSPI | ₩8,300 | −0.95% | ₩549M | ₩712B | 4.12% |
Komipharm International041960 · KOSDAQ | ₩8,280 | −3.94% | ₩2.8B | ₩618B | 0.02% |
Dong-A Pharmaceutical000640 · KOSPI | ₩87,900 | −2.12% | ₩1.9B | ₩592B | 9.45% |
Myungin Pharm317450 · KOSPI | ₩39,900 | −2.21% | ₩364M | ₩583B | 0.68% |
JW Pharmaceutical001060 · KOSPI | ₩23,100 | −3.35% | ₩630M | ₩568B | 2.44% |
Shinpoong Pharmaceutical019170 · KOSPI | ₩8,250 | −4.84% | ₩1.6B | ₩432B | 0.39% |
HLB Pharmaceutical047920 · KOSDAQ | ₩9,730 | −5.53% | ₩2.3B | ₩424B | — |
IL Dong Pharmaceutical249420 · KOSPI | ₩12,400 | −2.97% | ₩853M | ₩392B | 2.30% |
T&L340570 · KOSDAQ | ₩24,000 | −1.64% | ₩517M | ₩386B | 0.99% |
Bukwang Pharmaceutical IND003000 · KOSPI | ₩3,660 | −3.68% | ₩725M | ₩361B | 0.68% |
Dong-A ST170900 · KOSPI | ₩33,900 | −2.02% | ₩297M | ₩330B | 4.78% |
Kwangdong Pharmaceutical009290 · KOSPI | ₩6,450 | −2.12% | ₩677M | ₩321B | 0.80% |
Korea United Pharm033270 · KOSPI | ₩16,800 | −1.35% | ₩530M | ₩267B | 2.76% |
Huons Global084110 · KOSDAQ | ₩20,600 | −7.21% | ₩731M | ₩261B | 0.64% |
Samjin Pharmaceutical005500 · KOSPI | ₩19,160 | −2.24% | ₩576M | ₩255B | 2.05% |
Humedix200670 · KOSDAQ | ₩22,700 | −4.22% | ₩475M | ₩251B | 1.03% |
Hyundai Pharmaceutical004310 · KOSPI | ₩6,700 | −1.33% | ₩3B | ₩214B | 0.58% |
KolmarBNH200130 · KOSDAQ | ₩7,290 | −3.57% | ₩218M | ₩210B | 0.34% |
Suheung008490 · KOSPI | ₩17,950 | −0.99% | ₩161M | ₩208B | 0.94% |
Huons243070 · KOSDAQ | ₩16,850 | −2.99% | ₩515M | ₩202B | 0.71% |
HEM Pharma376270 · KOSDAQ | ₩27,900 | +0.18% | ₩90M | ₩201B | — |
GC WellBeing234690 · KOSDAQ | ₩10,870 | −3.21% | ₩3B | ₩195B | 0.35% |
Union Korea Pharm080720 · KOSDAQ | ₩2,410 | 0.00% | ₩0 | ₩192B | — |
Whanin Pharm016580 · KOSPI | ₩10,080 | −1.18% | ₩253M | ₩187B | 3.12% |
Reyon Pharmaceutical102460 · KOSPI | ₩9,730 | −0.10% | ₩425M | ₩181B | 0.61% |
DAE HWA Pharm067080 · KOSDAQ | ₩9,620 | −3.12% | ₩330M | ₩179B | 0.08% |
Chongkundang Holdings001630 · KOSPI | ₩35,400 | −0.42% | ₩82M | ₩177B | 4.29% |
Vivozon Pharmaceutical082800 · KOSDAQ | ₩2,900 | 0.00% | ₩169M | ₩176B | — |
Yungjin Pharm003520 · KOSPI | ₩945 | −4.16% | ₩390M | ₩173B | 0.49% |
Daewon Pharmaceutical003220 · KOSPI | ₩7,640 | −3.78% | ₩192M | ₩171B | 0.90% |
Samil Pharmaceutical000520 · KOSPI | ₩7,640 | −7.17% | ₩663M | ₩166B | 0.67% |
JW Lifescience234080 · KOSPI | ₩10,420 | −0.95% | ₩170M | ₩165B | 0.72% |
Daehan Pharmaceutical023910 · KOSDAQ | ₩25,200 | −0.40% | ₩80M | ₩151B | 1.35% |
Kyungdong Pharm011040 · KOSDAQ | ₩4,905 | +0.10% | ₩148M | ₩151B | 0.02% |
Hana Pharm293480 · KOSPI | ₩8,210 | −0.61% | ₩398M | ₩146B | 0.63% |
Dongwha Pharm000020 · KOSPI | ₩5,120 | −2.66% | ₩455M | ₩143B | 0.61% |
Ilyang Pharmaceutical007570 · KOSPI | ₩7,090 | +1.29% | ₩94M | ₩135B | 0.43% |
Jeil Pharmaceutical271980 · KOSPI | ₩8,890 | −0.78% | ₩142M | ₩131B | 0.70% |
Kyongbo Pharmaceutical214390 · KOSPI | ₩5,170 | +0.78% | ₩73M | ₩124B | 0.45% |
Ahn-Gook Pharmaceutical001540 · KOSDAQ | ₩9,190 | −0.65% | ₩278M | ₩120B | — |
Samsung Pharmaceutical001360 · KOSPI | ₩1,254 | −1.34% | ₩161M | ₩118B | 0.27% |
Dongsung Pharmaceutical002210 · KOSPI | ₩1,221 | −5.28% | ₩54M | ₩118B | 0.00% |
Handok002390 · KOSPI | ₩8,240 | −0.96% | ₩31M | ₩113B | 0.44% |
Jeil Pharma Holdings002620 · KOSPI | ₩7,040 | −2.22% | ₩8.4M | ₩112B | 0.44% |
Optus Pharmaceutical131030 · KOSDAQ | ₩5,750 | −3.20% | ₩66M | ₩101B | — |
Icure Pharmaceutical Incorporation175250 · KOSDAQ | ₩1,541 | +9.21% | ₩51M | ₩95B | 0.20% |
High Tech Pharm106190 · KOSDAQ | ₩8,880 | −2.63% | ₩209M | ₩94B | — |
DongKoo Bio & Pharma006620 · KOSDAQ | ₩3,230 | −2.12% | ₩275M | ₩92B | — |
Korea Pharma032300 · KOSDAQ | ₩8,110 | +1.00% | ₩127M | ₩88B | — |
Sam-A Pharm009300 · KOSDAQ | ₩13,760 | +1.47% | ₩11M | ₩88B | — |
Withus Pharmaceutical330350 · KOSDAQ | ₩6,410 | −1.84% | ₩174M | ₩85B | — |
CMG Pharmaceutical058820 · KOSDAQ | ₩562 | 0.00% | ₩0 | ₩83B | 0.03% |
Yuhan Pref.000105 · KOSPI | ₩68,100 | −3.13% | ₩19M | ₩78B | — |
Polaris AI Pharma041910 · KOSDAQ | ₩5,570 | −1.94% | ₩283M | ₩74B | — |
Daehan Nupharm054670 · KOSDAQ | ₩5,140 | −0.96% | ₩59M | ₩74B | — |
Shinil Pharmaceutical012790 · KOSDAQ | ₩6,150 | +0.16% | ₩120M | ₩74B | 0.39% |
Kukje Pharma002720 · KOSPI | ₩3,440 | −2.96% | ₩1.7B | ₩73B | 0.33% |
Samik Pharm014950 · KOSDAQ | ₩7,160 | −2.85% | ₩2.2B | ₩72B | — |
Ildong Holdings000230 · KOSPI | ₩5,780 | −1.70% | ₩72M | ₩67B | 0.32% |
CTC Bio060590 · KOSDAQ | ₩2,620 | −3.14% | ₩94M | ₩63B | — |
Sinsin Pharmaceutical002800 · KOSDAQ | ₩4,050 | −0.74% | ₩47M | ₩61B | — |
Yuyu Pharma000220 · KOSPI | ₩3,640 | −0.27% | ₩137M | ₩57B | 0.12% |
GL Pharm Tech204840 · KOSDAQ | ₩3,580 | −0.42% | ₩140M | ₩56B | — |
BL Pharmtech065170 · KOSDAQ | ₩1,832 | −3.63% | ₩293M | ₩51B | — |
JIN Yang Pharmaceutical007370 · KOSDAQ | ₩3,520 | −3.03% | ₩749M | ₩50B | — |
Hwail Pharm061250 · KOSDAQ | ₩5,820 | −1.69% | ₩36M | ₩49B | — |
CJ Bioscience311690 · KOSDAQ | ₩3,685 | +2.22% | ₩65M | ₩48B | — |
NovMetaPharma229500 · KONEX | ₩3,295 | −10.46% | ₩53M | ₩43B | — |
Myungmoon Pharm017180 · KOSPI | ₩1,200 | +0.17% | ₩134M | ₩41B | 0.30% |
Kyung NAM Pharm053950 · KOSDAQ | ₩1,753 | −0.74% | ₩42M | ₩34B | — |
Korean Drug014570 · KOSDAQ | ₩2,815 | −4.58% | ₩117M | ₩31B | — |
Korea Arlico Pharm260660 · KOSDAQ | ₩2,000 | −0.50% | ₩21M | ₩31B | — |
Bcworldpharm200780 · KOSDAQ | ₩2,825 | −0.88% | ₩6.1M | ₩30B | 0.20% |
Tdspharm464280 · KOSDAQ | ₩4,770 | −2.75% | ₩51M | ₩26B | — |
BASKHANBIOPharma354390 · KONEX | ₩3,550 | −0.14% | ₩6,855 | ₩25B | — |
Seoul Pharma018680 · KOSDAQ | ₩1,900 | +1.60% | ₩1.9M | ₩22B | — |
Poongjeon Pharmacy298060 · KOSDAQ | ₩2,200 | −3.30% | ₩8.2M | ₩21B | — |
Telcon RF Pharmaceutical200230 · KOSDAQ | ₩2,065 | −1.20% | ₩74M | ₩20B | 0.20% |
Plumbline Life Sciences222670 · KONEX | ₩4,635 | 0.00% | ₩0 | ₩19B | — |
ChoA Pharmaceutical034940 · KOSDAQ | ₩1,835 | −0.60% | ₩29M | ₩11B | — |
JW Pharmaceutical 2nd Pref.001067 · KOSPI | ₩49,750 | 0.00% | ₩0 | ₩10B | — |
Yuyu Pharma Pref.000225 · KOSPI | ₩3,525 | +0.28% | ₩54M | ₩8B | — |
JW Pharmaceutical Pref.001065 · KOSPI | ₩20,950 | −0.24% | ₩809,200 | ₩7.2B | — |
Kmpharmaceutical225430 · KOSDAQ | ₩698 | 0.00% | ₩0 | ₩4.5B | — |
Ilyang Pharmaceutical Pref.007575 · KOSPI | ₩7,100 | 0.00% | ₩71,000 | ₩3.2B | — |
Yuyu Pharma 2nd Pref.000227 · KOSPI | ₩7,470 | +0.40% | ₩4.5M | ₩2.4B | — |
Source: KRX statistical information